Hanson Wade light-logo dark-logo-new
Conference

3rd ADC Target Selection Summit

December 2023
Optimizing Target Selection Rationale for ADCs & Novel Format Conjugates
Precision Oncology
Conference

Tumour Models London

December 2023
Engineering Your Next Generation Tumour Models to Maximise Clinical Success
Precision Oncology
Conference

8th Oncolytic Virotherapy Summit

December 2023
Weaponize Oncolytic Viruses to Generate Robust Anti-Tumor Immunity
Precision Oncology
Conference

2nd Spatial Biology for Immuno-Oncology Summit

January 2024
Harness Spatial Technologies to Power Immunotherapy Research & Clinical Trials
Precision Oncology
Conference

8th Tumor Models San Francisco Summit

January 2024
Discover Tools to Progress Candidates to the Clinic & Avoid Costly Failures
Precision Oncology
Conference

7th DDR Inhibitors Summit

January 2024
Explore Novel DDR Targets, Maximize Combinations & Improve Patient Selection
Precision Oncology
Conference

8th Liquid Biopsy for Precision Oncology Summit

February 2024
Accelerating LBx Applications & Approvals Across the Continuum of Patient Care
Precision Oncology
Conference

14th World ADC London

March 2024
Maximising the Therapeutic Window of ADCs
Precision Oncology
Conference

5th Glioblastoma Drug Development Summit

March 2024
Revolutionize GBM Treatment for Development & Delivery of Effective Therapeutics
Precision Oncology
Conference

3rd ADC Analytical Development Summit

April 2024
Ensuring Your ADC's Product Quality, Identity & Potency
Precision Oncology
Conference

14th Clinical Biomarkers & CDx Summit Europe

April 2024
Fast-Tracking Clinical Biomarker & CDx Development in Oncology & Inflammatory Diseases
Precision Oncology
Conference

7th International Neoantigen Summit

April 2024
Supercharging the Clinical Translation of Efficacious Neoantigen Therapies
Precision Oncology
Conference

9th 3D Tissue Models Summit

May 2024
Integrating Advanced 3D Models to Empower Drug Discovery & Development
Precision Oncology
Conference

2nd ADC Toxicity Summit

July 2024
Minimizing Toxicities & Improving Tolerability to Maximize the TI of ADCs
Precision Oncology
Conference

12th Tumor Models Boston Summit

July 2024
Enhance Predictability & Translatability of Novel Combination Targeted Therapies
Precision Oncology
Conference

2nd ADC Linker & Conjugation Summit

August 2024
Optimize Your ADCs Chemistry to Improve Efficacy, Stability, and Reduce Off-Target Toxicities
Precision Oncology
Conference

ADC Process Development Summit

September 2024
Accelerate to First-In-Human Studies & Validate Robust Commercial Preparedness
Precision Oncology
Conference

14th World Clinical Biomarkers & CDx Summit

September 2024
Supercharging Development, Approval & Commercialization of Next Generation Companion Diagnostics
Precision Oncology
Conference

2nd Spatial Biology for Drug Development Summit

October 2024
Understanding Disease in a New Dimension
Precision Oncology
Conference

15th World ADC San Diego Summit

November 2024
The World’s Largest, Most Comprehensive & Definitive Antibody-Drug Conjugate Event
Precision Oncology
Conference

3rd LBx Surveillance & Early Detection Summit

November 2024
Recognizing Disease Hallmarks Earlier for Improved Patient Outcomes
Precision Oncology

View and search all of our conferences.

ConferencesView All Conferences

Accelerating the Development of More Efficacious Precision Oncology Therapeutics

Testimonials

“I’m looking forward to attending and presenting at the World Clinical Biomarkers & CDx Summit. This is a key meeting for researchers, biomarker developers and Pharma to connect and shape the future of Precision Medicine.”

Amy Gorman
Director, Global Commercial Strategy, Precision Medicine, Janssen

“This conference has been very insightful in the past as the field of CDx is still advancing and we can learn from each other’s experiences.”

Silva Krause
Senior Director, Clinical Biomarkers, Vertex Pharmaceuticals

“Very rewarding. Resulted in several big pharma collaborations.”

Co-Founder & CEO, Aracari Biosciences

“Really enjoyed the conference. Great integration with speakers and delegates. The small size made it easier to make connections. Overall, the quality of the speakers and delegates was very high. I would definitely recommend it and hope to return next year.”

Group Lead, Gamma Delta Therapeutics

Precision Oncology Conferences – Product Team

Fiona Mistri, MSc

Group Managing Director

Elayda Hearne, MSc

Portfolio Director

Tom Cosgrove

Brand Director

George McNamara

Brand Director

Other Precision Oncology Product Types

Expert-driven, Life Science Market Intelligence Solutions

Explore More

Make Faster, Better Drug Development Decisions

Explore More

CONTACT US

Get in touch

We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.

Standard Form - Precision Oncology

"*" indicates required fields

Fill out the form below with your question and one of our team will get back to you.